Industry Research Reports

Home > Reports > Chemical & Material > Global Tacrolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Tacrolimus API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-11-09

Pages: 107 Pages

Report ld: 5404495

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Tacrolimus API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Tacrolimus API market competitiveness, regional economic performance, and supply chain configurations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Tacrolimus API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Hangzhou Zhongmei Huadong Pharmaceutical
Guangzhou Tosun Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
Dr. Reddy's Laboratories
Zeon Health Industries
Fishfa Biogenics
Teva API
Apotex Fermentation Inc.
Astellas Pharma
Bills Biotech
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Lek Pharmaceuticals
Murli Krishna Pharma
Viruj Pharmaceuticals Pvt. Ltd
Zhejiang Hisun Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0.98
0.99
Others

Segment by Application

Capsules
Injection
Ointments
Eye Drops
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Tacrolimus API market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 0.99 in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Injection in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tacrolimus API value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Tacrolimus API Product Scope

1.2 Tacrolimus API by Type

1.2.1 Global Tacrolimus API Sales by Type (2020 & 2024 & 2031)

1.2.2 0.98

1.2.3 0.99

1.2.4 Others

1.3 Tacrolimus API by Application

1.3.1 Global Tacrolimus API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Capsules

1.3.3 Injection

1.3.4 Ointments

1.3.5 Eye Drops

1.3.6 Others

1.4 Global Tacrolimus API Market Estimates and Forecasts (2020-2031)

1.4.1 Global Tacrolimus API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Tacrolimus API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Tacrolimus API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Tacrolimus API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Tacrolimus API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Tacrolimus API Sales Market Share by Region (2020-2025)

2.2.2 Global Tacrolimus API Revenue Market Share by Region (2020-2025)

2.3 Global Tacrolimus API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Tacrolimus API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Tacrolimus API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Tacrolimus API Market Size and Prospective (2020-2031)

2.4.2 Europe Tacrolimus API Market Size and Prospective (2020-2031)

2.4.3 China Tacrolimus API Market Size and Prospective (2020-2031)

2.4.4 Japan Tacrolimus API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Tacrolimus API Historic Market Review by Type (2020-2025)

3.1.1 Global Tacrolimus API Sales by Type (2020-2025)

3.1.2 Global Tacrolimus API Revenue by Type (2020-2025)

3.1.3 Global Tacrolimus API Price by Type (2020-2025)

3.2 Global Tacrolimus API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Tacrolimus API Sales Forecast by Type (2026-2031)

3.2.2 Global Tacrolimus API Revenue Forecast by Type (2026-2031)

3.2.3 Global Tacrolimus API Price Forecast by Type (2026-2031)

3.3 Different Types Tacrolimus API Representative Players

4 Global Market Size by Application

4.1 Global Tacrolimus API Historic Market Review by Application (2020-2025)

4.1.1 Global Tacrolimus API Sales by Application (2020-2025)

4.1.2 Global Tacrolimus API Revenue by Application (2020-2025)

4.1.3 Global Tacrolimus API Price by Application (2020-2025)

4.2 Global Tacrolimus API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Tacrolimus API Sales Forecast by Application (2026-2031)

4.2.2 Global Tacrolimus API Revenue Forecast by Application (2026-2031)

4.2.3 Global Tacrolimus API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Tacrolimus API Application

5 Competition Landscape by Players

5.1 Global Tacrolimus API Sales by Players (2020-2025)

5.2 Global Top Tacrolimus API Players by Revenue (2020-2025)

5.3 Global Tacrolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus API as of 2024)

5.4 Global Tacrolimus API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Tacrolimus API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Tacrolimus API, Product Type & Application

5.7 Global Key Manufacturers of Tacrolimus API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Tacrolimus API Sales by Company

6.1.1.1 North America Tacrolimus API Sales by Company (2020-2025)

6.1.1.2 North America Tacrolimus API Revenue by Company (2020-2025)

6.1.2 North America Tacrolimus API Sales Breakdown by Type (2020-2025)

6.1.3 North America Tacrolimus API Sales Breakdown by Application (2020-2025)

6.1.4 North America Tacrolimus API Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Tacrolimus API Sales by Company

6.2.1.1 Europe Tacrolimus API Sales by Company (2020-2025)

6.2.1.2 Europe Tacrolimus API Revenue by Company (2020-2025)

6.2.2 Europe Tacrolimus API Sales Breakdown by Type (2020-2025)

6.2.3 Europe Tacrolimus API Sales Breakdown by Application (2020-2025)

6.2.4 Europe Tacrolimus API Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Tacrolimus API Sales by Company

6.3.1.1 China Tacrolimus API Sales by Company (2020-2025)

6.3.1.2 China Tacrolimus API Revenue by Company (2020-2025)

6.3.2 China Tacrolimus API Sales Breakdown by Type (2020-2025)

6.3.3 China Tacrolimus API Sales Breakdown by Application (2020-2025)

6.3.4 China Tacrolimus API Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Tacrolimus API Sales by Company

6.4.1.1 Japan Tacrolimus API Sales by Company (2020-2025)

6.4.1.2 Japan Tacrolimus API Revenue by Company (2020-2025)

6.4.2 Japan Tacrolimus API Sales Breakdown by Type (2020-2025)

6.4.3 Japan Tacrolimus API Sales Breakdown by Application (2020-2025)

6.4.4 Japan Tacrolimus API Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Hangzhou Zhongmei Huadong Pharmaceutical

7.1.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information

7.1.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview

7.1.3 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Products Offered

7.1.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Development

7.2 Guangzhou Tosun Pharmaceutical

7.2.1 Guangzhou Tosun Pharmaceutical Company Information

7.2.2 Guangzhou Tosun Pharmaceutical Business Overview

7.2.3 Guangzhou Tosun Pharmaceutical Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Guangzhou Tosun Pharmaceutical Tacrolimus API Products Offered

7.2.5 Guangzhou Tosun Pharmaceutical Recent Development

7.3 Chunghwa Chemical Synthesis & Biotech

7.3.1 Chunghwa Chemical Synthesis & Biotech Company Information

7.3.2 Chunghwa Chemical Synthesis & Biotech Business Overview

7.3.3 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Products Offered

7.3.5 Chunghwa Chemical Synthesis & Biotech Recent Development

7.4 ChemWerth Inc

7.4.1 ChemWerth Inc Company Information

7.4.2 ChemWerth Inc Business Overview

7.4.3 ChemWerth Inc Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 ChemWerth Inc Tacrolimus API Products Offered

7.4.5 ChemWerth Inc Recent Development

7.5 Dr. Reddy's Laboratories

7.5.1 Dr. Reddy's Laboratories Company Information

7.5.2 Dr. Reddy's Laboratories Business Overview

7.5.3 Dr. Reddy's Laboratories Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Dr. Reddy's Laboratories Tacrolimus API Products Offered

7.5.5 Dr. Reddy's Laboratories Recent Development

7.6 Zeon Health Industries

7.6.1 Zeon Health Industries Company Information

7.6.2 Zeon Health Industries Business Overview

7.6.3 Zeon Health Industries Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Zeon Health Industries Tacrolimus API Products Offered

7.6.5 Zeon Health Industries Recent Development

7.7 Fishfa Biogenics

7.7.1 Fishfa Biogenics Company Information

7.7.2 Fishfa Biogenics Business Overview

7.7.3 Fishfa Biogenics Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Fishfa Biogenics Tacrolimus API Products Offered

7.7.5 Fishfa Biogenics Recent Development

7.8 Teva API

7.8.1 Teva API Company Information

7.8.2 Teva API Business Overview

7.8.3 Teva API Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Teva API Tacrolimus API Products Offered

7.8.5 Teva API Recent Development

7.9 Apotex Fermentation Inc.

7.9.1 Apotex Fermentation Inc. Company Information

7.9.2 Apotex Fermentation Inc. Business Overview

7.9.3 Apotex Fermentation Inc. Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Apotex Fermentation Inc. Tacrolimus API Products Offered

7.9.5 Apotex Fermentation Inc. Recent Development

7.10 Astellas Pharma

7.10.1 Astellas Pharma Company Information

7.10.2 Astellas Pharma Business Overview

7.10.3 Astellas Pharma Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Astellas Pharma Tacrolimus API Products Offered

7.10.5 Astellas Pharma Recent Development

7.11 Bills Biotech

7.11.1 Bills Biotech Company Information

7.11.2 Bills Biotech Business Overview

7.11.3 Bills Biotech Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Bills Biotech Tacrolimus API Products Offered

7.11.5 Bills Biotech Recent Development

7.12 CKD Bio Corporation

7.12.1 CKD Bio Corporation Company Information

7.12.2 CKD Bio Corporation Business Overview

7.12.3 CKD Bio Corporation Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.12.4 CKD Bio Corporation Tacrolimus API Products Offered

7.12.5 CKD Bio Corporation Recent Development

7.13 Concord Biotech

7.13.1 Concord Biotech Company Information

7.13.2 Concord Biotech Business Overview

7.13.3 Concord Biotech Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Concord Biotech Tacrolimus API Products Offered

7.13.5 Concord Biotech Recent Development

7.14 JOYANG LABORATORIES

7.14.1 JOYANG LABORATORIES Company Information

7.14.2 JOYANG LABORATORIES Business Overview

7.14.3 JOYANG LABORATORIES Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.14.4 JOYANG LABORATORIES Tacrolimus API Products Offered

7.14.5 JOYANG LABORATORIES Recent Development

7.15 Lek Pharmaceuticals

7.15.1 Lek Pharmaceuticals Company Information

7.15.2 Lek Pharmaceuticals Business Overview

7.15.3 Lek Pharmaceuticals Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.15.4 Lek Pharmaceuticals Tacrolimus API Products Offered

7.15.5 Lek Pharmaceuticals Recent Development

7.16 Murli Krishna Pharma

7.16.1 Murli Krishna Pharma Company Information

7.16.2 Murli Krishna Pharma Business Overview

7.16.3 Murli Krishna Pharma Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.16.4 Murli Krishna Pharma Tacrolimus API Products Offered

7.16.5 Murli Krishna Pharma Recent Development

7.17 Viruj Pharmaceuticals Pvt. Ltd

7.17.1 Viruj Pharmaceuticals Pvt. Ltd Company Information

7.17.2 Viruj Pharmaceuticals Pvt. Ltd Business Overview

7.17.3 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Products Offered

7.17.5 Viruj Pharmaceuticals Pvt. Ltd Recent Development

7.18 Zhejiang Hisun Pharmaceutical

7.18.1 Zhejiang Hisun Pharmaceutical Company Information

7.18.2 Zhejiang Hisun Pharmaceutical Business Overview

7.18.3 Zhejiang Hisun Pharmaceutical Tacrolimus API Sales, Revenue and Gross Margin (2020-2025)

7.18.4 Zhejiang Hisun Pharmaceutical Tacrolimus API Products Offered

7.18.5 Zhejiang Hisun Pharmaceutical Recent Development

8 Tacrolimus API Manufacturing Cost Analysis

8.1 Tacrolimus API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Tacrolimus API

8.4 Tacrolimus API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Tacrolimus API Distributors List

9.3 Tacrolimus API Customers

10 Tacrolimus API Market Dynamics

10.1 Tacrolimus API Industry Trends

10.2 Tacrolimus API Market Drivers

10.3 Tacrolimus API Market Challenges

10.4 Tacrolimus API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tacrolimus API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Tacrolimus API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Tacrolimus API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Tacrolimus API Sales (Tons) by Region (2020-2025)

Table 5. Global Tacrolimus API Sales Market Share by Region (2020-2025)

Table 6. Global Tacrolimus API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Tacrolimus API Revenue Share by Region (2020-2025)

Table 8. Global Tacrolimus API Sales (Tons) Forecast by Region (2026-2031)

Table 9. Global Tacrolimus API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Tacrolimus API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Tacrolimus API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Tacrolimus API Sales by Type (Tons) & (2020-2025)

Table 13. Global Tacrolimus API Sales Share by Type (2020-2025)

Table 14. Global Tacrolimus API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Tacrolimus API Price by Type (US$/Kg) & (2020-2025)

Table 16. Global Tacrolimus API Sales by Type (Tons) & (2026-2031)

Table 17. Global Tacrolimus API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Tacrolimus API Price by Type (US$/Kg) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Tacrolimus API Sales by Application (Tons) & (2020-2025)

Table 21. Global Tacrolimus API Sales Share by Application (2020-2025)

Table 22. Global Tacrolimus API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Tacrolimus API Price by Application (US$/Kg) & (2020-2025)

Table 24. Global Tacrolimus API Sales by Application (Tons) & (2026-2031)

Table 25. Global Tacrolimus API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Tacrolimus API Price by Application (US$/Kg) & (2026-2031)

Table 27. New Sources of Growth in Tacrolimus API Application

Table 28. Global Tacrolimus API Sales by Company (Tons) & (2020-2025)

Table 29. Global Tacrolimus API Sales Share by Company (2020-2025)

Table 30. Global Tacrolimus API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Tacrolimus API Revenue Share by Company (2020-2025)

Table 32. Global Tacrolimus API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus API as of 2024)

Table 33. Global Market Tacrolimus API Average Price by Company (US$/Kg) & (2020-2025)

Table 34. Global Key Manufacturers of Tacrolimus API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Tacrolimus API, Product Type & Application

Table 36. Global Key Manufacturers of Tacrolimus API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Tacrolimus API Sales by Company (2020-2025) & (Tons)

Table 39. North America Tacrolimus API Sales Market Share by Company (2020-2025)

Table 40. North America Tacrolimus API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Tacrolimus API Revenue Market Share by Company (2020-2025)

Table 42. North America Tacrolimus API Sales by Type (2020-2025) & (Tons)

Table 43. North America Tacrolimus API Sales Market Share by Type (2020-2025)

Table 44. North America Tacrolimus API Sales by Application (2020-2025) & (Tons)

Table 45. North America Tacrolimus API Sales Market Share by Application (2020-2025)

Table 46. Europe Tacrolimus API Sales by Company (2020-2025) & (Tons)

Table 47. Europe Tacrolimus API Sales Market Share by Company (2020-2025)

Table 48. Europe Tacrolimus API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Tacrolimus API Revenue Market Share by Company (2020-2025)

Table 50. Europe Tacrolimus API Sales by Type (2020-2025) & (Tons)

Table 51. Europe Tacrolimus API Sales Market Share by Type (2020-2025)

Table 52. Europe Tacrolimus API Sales by Application (2020-2025) & (Tons)

Table 53. Europe Tacrolimus API Sales Market Share by Application (2020-2025)

Table 54. China Tacrolimus API Sales by Company (2020-2025) & (Tons)

Table 55. China Tacrolimus API Sales Market Share by Company (2020-2025)

Table 56. China Tacrolimus API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Tacrolimus API Revenue Market Share by Company (2020-2025)

Table 58. China Tacrolimus API Sales by Type (2020-2025) & (Tons)

Table 59. China Tacrolimus API Sales Market Share by Type (2020-2025)

Table 60. China Tacrolimus API Sales by Application (2020-2025) & (Tons)

Table 61. China Tacrolimus API Sales Market Share by Application (2020-2025)

Table 62. Japan Tacrolimus API Sales by Company (2020-2025) & (Tons)

Table 63. Japan Tacrolimus API Sales Market Share by Company (2020-2025)

Table 64. Japan Tacrolimus API Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Tacrolimus API Revenue Market Share by Company (2020-2025)

Table 66. Japan Tacrolimus API Sales by Type (2020-2025) & (Tons)

Table 67. Japan Tacrolimus API Sales Market Share by Type (2020-2025)

Table 68. Japan Tacrolimus API Sales by Application (2020-2025) & (Tons)

Table 69. Japan Tacrolimus API Sales Market Share by Application (2020-2025)

Table 70. Hangzhou Zhongmei Huadong Pharmaceutical Company Information

Table 71. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview

Table 72. Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Product

Table 74. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development

Table 75. Guangzhou Tosun Pharmaceutical Company Information

Table 76. Guangzhou Tosun Pharmaceutical Description and Business Overview

Table 77. Guangzhou Tosun Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Guangzhou Tosun Pharmaceutical Tacrolimus API Product

Table 79. Guangzhou Tosun Pharmaceutical Recent Development

Table 80. Chunghwa Chemical Synthesis & Biotech Company Information

Table 81. Chunghwa Chemical Synthesis & Biotech Description and Business Overview

Table 82. Chunghwa Chemical Synthesis & Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Chunghwa Chemical Synthesis & Biotech Tacrolimus API Product

Table 84. Chunghwa Chemical Synthesis & Biotech Recent Development

Table 85. ChemWerth Inc Company Information

Table 86. ChemWerth Inc Description and Business Overview

Table 87. ChemWerth Inc Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. ChemWerth Inc Tacrolimus API Product

Table 89. ChemWerth Inc Recent Development

Table 90. Dr. Reddy's Laboratories Company Information

Table 91. Dr. Reddy's Laboratories Description and Business Overview

Table 92. Dr. Reddy's Laboratories Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Dr. Reddy's Laboratories Tacrolimus API Product

Table 94. Dr. Reddy's Laboratories Recent Development

Table 95. Zeon Health Industries Company Information

Table 96. Zeon Health Industries Description and Business Overview

Table 97. Zeon Health Industries Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Zeon Health Industries Tacrolimus API Product

Table 99. Zeon Health Industries Recent Development

Table 100. Fishfa Biogenics Company Information

Table 101. Fishfa Biogenics Description and Business Overview

Table 102. Fishfa Biogenics Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Fishfa Biogenics Tacrolimus API Product

Table 104. Fishfa Biogenics Recent Development

Table 105. Teva API Company Information

Table 106. Teva API Description and Business Overview

Table 107. Teva API Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Teva API Tacrolimus API Product

Table 109. Teva API Recent Development

Table 110. Apotex Fermentation Inc. Company Information

Table 111. Apotex Fermentation Inc. Description and Business Overview

Table 112. Apotex Fermentation Inc. Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Apotex Fermentation Inc. Tacrolimus API Product

Table 114. Apotex Fermentation Inc. Recent Development

Table 115. Astellas Pharma Company Information

Table 116. Astellas Pharma Description and Business Overview

Table 117. Astellas Pharma Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Astellas Pharma Tacrolimus API Product

Table 119. Astellas Pharma Recent Development

Table 120. Bills Biotech Company Information

Table 121. Bills Biotech Description and Business Overview

Table 122. Bills Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Bills Biotech Tacrolimus API Product

Table 124. Bills Biotech Recent Development

Table 125. CKD Bio Corporation Company Information

Table 126. CKD Bio Corporation Description and Business Overview

Table 127. CKD Bio Corporation Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. CKD Bio Corporation Tacrolimus API Product

Table 129. CKD Bio Corporation Recent Development

Table 130. Concord Biotech Company Information

Table 131. Concord Biotech Description and Business Overview

Table 132. Concord Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Concord Biotech Tacrolimus API Product

Table 134. Concord Biotech Recent Development

Table 135. JOYANG LABORATORIES Company Information

Table 136. JOYANG LABORATORIES Description and Business Overview

Table 137. JOYANG LABORATORIES Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. JOYANG LABORATORIES Tacrolimus API Product

Table 139. JOYANG LABORATORIES Recent Development

Table 140. Lek Pharmaceuticals Company Information

Table 141. Lek Pharmaceuticals Description and Business Overview

Table 142. Lek Pharmaceuticals Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 143. Lek Pharmaceuticals Tacrolimus API Product

Table 144. Lek Pharmaceuticals Recent Development

Table 145. Murli Krishna Pharma Company Information

Table 146. Murli Krishna Pharma Description and Business Overview

Table 147. Murli Krishna Pharma Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 148. Murli Krishna Pharma Tacrolimus API Product

Table 149. Murli Krishna Pharma Recent Development

Table 150. Viruj Pharmaceuticals Pvt. Ltd Company Information

Table 151. Viruj Pharmaceuticals Pvt. Ltd Description and Business Overview

Table 152. Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 153. Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Product

Table 154. Viruj Pharmaceuticals Pvt. Ltd Recent Development

Table 155. Zhejiang Hisun Pharmaceutical Company Information

Table 156. Zhejiang Hisun Pharmaceutical Description and Business Overview

Table 157. Zhejiang Hisun Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 158. Zhejiang Hisun Pharmaceutical Tacrolimus API Product

Table 159. Zhejiang Hisun Pharmaceutical Recent Development

Table 160. Production Base and Market Concentration Rate of Raw Material

Table 161. Key Suppliers of Raw Materials

Table 162. Tacrolimus API Distributors List

Table 163. Tacrolimus API Customers List

Table 164. Tacrolimus API Market Trends

Table 165. Tacrolimus API Market Drivers

Table 166. Tacrolimus API Market Challenges

Table 167. Tacrolimus API Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Tacrolimus API Product Picture

Figure 2. Global Tacrolimus API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Tacrolimus API Sales Market Share by Type in 2024 & 2031

Figure 4. 0.98 Product Picture

Figure 5. 0.99 Product Picture

Figure 6. Others Product Picture

Figure 7. Global Tacrolimus API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Tacrolimus API Sales Market Share by Application in 2024 & 2031

Figure 9. Capsules Examples

Figure 10. Injection Examples

Figure 11. Ointments Examples

Figure 12. Eye Drops Examples

Figure 13. Others Examples

Figure 14. Global Tacrolimus API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Tacrolimus API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 16. Global Tacrolimus API Sales (Tons) Growth Rate (2020-2031)

Figure 17. Global Tacrolimus API Price Trends Growth Rate (2020-2031) & (US$/Kg)

Figure 18. Tacrolimus API Report Years Considered

Figure 19. Global Market Tacrolimus API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 20. Global Tacrolimus API Revenue Market Share by Region: 2020 VS 2024

Figure 21. North America Tacrolimus API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. North America Tacrolimus API Sales (Tons) Growth Rate (2020-2031)

Figure 23. Europe Tacrolimus API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Europe Tacrolimus API Sales (Tons) Growth Rate (2020-2031)

Figure 25. China Tacrolimus API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. China Tacrolimus API Sales (Tons) Growth Rate (2020-2031)

Figure 27. Japan Tacrolimus API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Tacrolimus API Sales (Tons) Growth Rate (2020-2031)

Figure 29. Global Tacrolimus API Revenue Share by Type (2020-2025)

Figure 30. Global Tacrolimus API Sales Share by Type (2026-2031)

Figure 31. Global Tacrolimus API Revenue Share by Type (2026-2031)

Figure 32. Global Tacrolimus API Revenue Share by Application (2020-2025)

Figure 33. Global Tacrolimus API Revenue Growth Rate by Application in 2020 & 2024

Figure 34. Global Tacrolimus API Sales Share by Application (2026-2031)

Figure 35. Global Tacrolimus API Revenue Share by Application (2026-2031)

Figure 36. Global Tacrolimus API Sales Share by Company (2024)

Figure 37. Global Tacrolimus API Revenue Share by Company (2024)

Figure 38. Global 5 Largest Tacrolimus API Players Market Share by Revenue in Tacrolimus API: 2020 & 2024

Figure 39. Tacrolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 40. Manufacturing Cost Structure of Tacrolimus API

Figure 41. Manufacturing Process Analysis of Tacrolimus API

Figure 42. Tacrolimus API Industrial Chain

Figure 43. Channels of Distribution (Direct Vs Distribution)

Figure 44. Distributors Profiles

Figure 45. Bottom-up and Top-down Approaches for This Report

Figure 46. Data Triangulation

Figure 47. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tacrolimus API market? zhanKai

The top companies in the global Tacrolimus API market are Hangzhou Zhongmei Huadong Pharmaceutical、Guangzhou Tosun Pharmaceutical、Chunghwa Chemical Synthesis & Biotech.

Related Reports

Tacrolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tacrolimus API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 147
USD 3950.00
(Single User License)
Global Tacrolimus API Market Research Report 2026
The global Tacrolimus API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 148
USD 2900.00
(Single User License)
Global Tacrolimus API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tacrolimus API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 178
USD 4900.00
(Single User License)
Tacrolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Tacrolimus API Market Research Report 2025
The global market for Tacrolimus API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 107
USD 2900.00
(Single User License)
Global Tacrolimus API Market Research Report 2024
The global Tacrolimus API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 113
USD 2900.00
(Single User License)

Tacrolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tacrolimus API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 147
USD 3950.00 (Single User License)
Global Tacrolimus API Market Research Report 2026
The global Tacrolimus API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 148
USD 2900.00 (Single User License)
Global Tacrolimus API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tacrolimus API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 178
USD 4900.00 (Single User License)
Tacrolimus API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)
Global Tacrolimus API Market Research Report 2025
The global market for Tacrolimus API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 107
USD 2900.00 (Single User License)
Global Tacrolimus API Market Research Report 2024
The global Tacrolimus API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 113
USD 2900.00 (Single User License)